Cases & Deals

  • Home
  • Practices
  • Bpifrance sells interests in HalioDx to Veracyte, Inc.

Share

Bpifrance sells interests in HalioDx to Veracyte, Inc.

August 2021

Client(s) Bpifrance

Jones Day represented Bpifrance in the sale of its interests in HalioDx, a French private biotech company specialized in immune-based diagnostic products and services, as part of the €260 million sale of HalioDx to Veracyte, Inc., a U.S. global genomic diagnostics company listed on the Nasdaq.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.